Literature DB >> 21357764

Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments.

Kenneth D Gibbs1, Penney M Gilbert, Karen Sachs, Feifei Zhao, Helen M Blau, Irving L Weissman, Garry P Nolan, Ravindra Majeti.   

Abstract

The low frequency of hematopoietic stem and progenitor cells (HSPCs) in human BM has precluded analysis of the direct biochemical effects elicited by cytokines in these populations, and their functional consequences. Here, single-cell phospho-specific flow cytometry was used to define the signaling networks active in 5 previously defined human HSPC subsets. This analysis revealed that the currently defined HSC compartment is composed of biochemically distinct subsets with the ability to respond rapidly and directly in vitro to a broader array of cytokines than previously appreciated, including G-CSF. The G-CSF response was physiologically relevant-driving cell-cycle entry and increased proliferation in a subset of single cells within the HSC compartment. The heterogeneity in the single-cell signaling and proliferation responses prompted subfractionation of the adult BM HSC compartment by expression of CD114 (G-CSF receptor). Xenotransplantation assays revealed that HSC activity is significantly enriched in the CD114(neg/lo) compartment, and almost completely absent in the CD114(pos) subfraction. The single-cell analyses used here can be adapted for further refinement of HSPC surface immunophenotypes, and for examining the direct regulatory effects of other factors on the homeostasis of stem and progenitor populations in normal or diseased states.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357764      PMCID: PMC3087474          DOI: 10.1182/blood-2010-07-298232

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Dendritic cell-based cancer immunotherapy: potential for treatment of colorectal cancer?

Authors:  W Chen; N Rains; D Young; R S Stubbs
Journal:  J Gastroenterol Hepatol       Date:  2000-07       Impact factor: 4.029

Review 3.  Dendritic cell apoptosis: regulation of tolerance versus immunity.

Authors:  Rahul Kushwah; Jim Hu
Journal:  J Immunol       Date:  2010-07-15       Impact factor: 5.422

4.  Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression.

Authors:  S I Hashimoto; T Suzuki; S Nagai; T Yamashita; N Toyoda; K Matsushima
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

5.  MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development.

Authors:  Ryan M O'Connell; Daniel Kahn; William S J Gibson; June L Round; Rebecca L Scholz; Aadel A Chaudhuri; Melissa E Kahn; Dinesh S Rao; David Baltimore
Journal:  Immunity       Date:  2010-09-30       Impact factor: 31.745

Review 6.  Programmed cell death of dendritic cells in immune regulation.

Authors:  Min Chen; Jin Wang
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

7.  Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.

Authors:  Bangxing Hong; Wenhong Ren; Xiao-Tong Song; Kevin Evel-Kabler; Si-Yi Chen; Xue F Huang
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

8.  Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy.

Authors:  Kim Holmstrøm; Ayako Wakatsuki Pedersen; Mogens Helweg Claesson; Mai-Britt Zocca; Simon Skjøde Jensen
Journal:  Hum Immunol       Date:  2010-01       Impact factor: 2.850

9.  Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.

Authors:  Jong-Kook Park; Eun Joo Lee; Christine Esau; Thomas D Schmittgen
Journal:  Pancreas       Date:  2009-10       Impact factor: 3.327

10.  MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.

Authors:  Laura Gramantieri; Francesca Fornari; Manuela Ferracin; Angelo Veronese; Silvia Sabbioni; George Adrian Calin; Gian Luca Grazi; Carlo Maria Croce; Luigi Bolondi; Massimo Negrini
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

View more
  22 in total

1.  Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML.

Authors:  Kenneth D Gibbs; Astraea Jager; Oliver Crespo; Yury Goltsev; Angelica Trejo; Chase E Richard; Garry P Nolan
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Phosphoproteomic profiling of mouse primary HSPCs reveals new regulators of HSPC mobilization.

Authors:  Leo D Wang; Scott B Ficarro; John N Hutchinson; Roland Csepanyi-Komi; Phi T Nguyen; Eva Wisniewski; Jessica Sullivan; Oliver Hofmann; Erzsebet Ligeti; Jarrod A Marto; Amy J Wagers
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

3.  Identification of functionally primitive and immunophenotypically distinct subpopulations in secondary acute myeloid leukemia by mass cytometry.

Authors:  Shovik Bandyopadhyay; Jared S Fowles; Liyang Yu; Daniel A C Fisher; Stephen T Oh
Journal:  Cytometry B Clin Cytom       Date:  2018-11-13       Impact factor: 3.058

Review 4.  Aging, hematopoiesis, and the myelodysplastic syndromes.

Authors:  Stephen S Chung; Christopher Y Park
Journal:  Blood Adv       Date:  2017-12-08

Review 5.  Aging, hematopoiesis, and the myelodysplastic syndromes.

Authors:  Stephen S Chung; Christopher Y Park
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.

Authors:  Jacob H Levine; Erin F Simonds; Sean C Bendall; Kara L Davis; El-ad D Amir; Michelle D Tadmor; Oren Litvin; Harris G Fienberg; Astraea Jager; Eli R Zunder; Rachel Finck; Amanda L Gedman; Ina Radtke; James R Downing; Dana Pe'er; Garry P Nolan
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

7.  Intrinsic resistance to JAK2 inhibition in myelofibrosis.

Authors:  Anna Kalota; Grace R Jeschke; Martin Carroll; Elizabeth O Hexner
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

8.  FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.

Authors:  Michele S Redell; Marcos J Ruiz; Robert B Gerbing; Todd A Alonzo; Beverly J Lange; David J Tweardy; Soheil Meshinchi
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

9.  Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.

Authors:  Norman J Lacayo; Todd A Alonzo; Urte Gayko; David B Rosen; Matt Westfall; Norman Purvis; Santosh Putta; Brent Louie; James Hackett; Aileen Cleary Cohen; Alessandra Cesano; Robert Gerbing; Yaddanapudi Ravindranath; Gary V Dahl; Alan Gamis; Soheil Meshinchi
Journal:  Br J Haematol       Date:  2013-05-20       Impact factor: 6.998

Review 10.  STAT5 in hematopoietic stem cell biology and transplantation.

Authors:  Zhengqi Wang; Kevin D Bunting
Journal:  JAKSTAT       Date:  2013-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.